Stock

The Wall Avenue Journal: Biden chooses former FDA chief Robert Califf because the company's new head

Robert Califf, a former commissioner for the Food and Drug Administration, is expected to be the Biden administration's choice to re-head the agency, said people familiar with the matter, as the FDA has a pivotal role in efforts to combat Covid-19 -Pandemic is playing.

President Biden is expected to announce the nomination on Friday, one of the people said. The FDA, which has approved the use of Covid-19 vaccines, boosters, and drugs, has been operating without a permanent guide since Mr. Biden took office.

If confirmed, Dr. To replace Califf from Acting Commissioner Janet Woodcock. Dr. Califf, a noted Duke University cardiologist, has worked with drug companies on clinical trials and led the FDA in 2016 and early 2017 under the Obama administration.

He would run a $ 6 billion agency with 18,000 employees working on tight schedules to determine whether experimental Covid-19 shots and drugs work safely for widespread use.

An expanded version of this story appears on WSJ.com.

Popular Stories from WSJ.com:

Related Articles